Stimulation of medial prefrontal cortex serotonin 2C (5-HT(2C)) receptors attenuates cocaine-seeking behavior. 2010

Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
Department of Psychology, Arizona State University, Tempe, 85287-1104, USA.

Serotonin 2C receptor (5-HT(2C)R) agonists administered systemically attenuate both cocaine-primed and cue-elicited reinstatement of extinguished cocaine-seeking behavior. To further elucidate the function of these receptors in addiction-like processes, this study examined the effects of microinfusing the 5-HT(2C)R agonist MK212 (0, 10, 30, 100 ng/side/0.2 microl) into the medial prefrontal cortex (mPFC) on cocaine self-administration and reinstatement of extinguished cocaine-seeking behavior. Male Sprague-Dawley rats were trained to self-administer cocaine (0.75 mg/kg, i.v.) paired with light and tone cues. Once responding stabilized, rats received MK212 microinfusions before tests for maintenance of cocaine self-administration. Next, extinction training to reduce cocaine-seeking behavior, defined as responses performed without cocaine reinforcement available, occurred until low extinction baselines were achieved. Rats then received MK212 microinfusions before tests for reinstatement of extinguished cocaine-seeking behavior elicited by cocaine-priming injections (10 mg/kg, i.p.) or response-contingent presentations of the cocaine-associated cues; operant responses during cocaine-primed reinstatement tests produced no consequences. MK212 microinfusions into the prelimbic and infralimbic, but not anterior cingulate, regions of the mPFC dose-dependently attenuated both cocaine-primed and cue-elicited reinstatement of extinguished cocaine-seeking behavior, but did not reliably affect cocaine self-administration. A subsequent experiment showed that the effects of MK212 (100 ng/side/0.2 microl) on reinstatement of extinguished cocaine-seeking behavior were blocked by co-administration of the 5-HT(2C)R antagonist SB242084 (200 ng/side/0.2 microl). MK212 administered alone into the mPFC as a drug prime produced no discernable effects on cocaine-seeking behavior. These findings suggest that stimulation of 5-HT(2C)Rs in the mPFC attenuates the incentive motivational effects produced by sampling cocaine or exposure to drug-paired cues.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D011719 Pyrazines A heterocyclic aromatic organic compound with the chemical formula C4H4N2. Pyrazine
D012054 Reinforcement, Psychology The strengthening of a conditioned response. Negative Reinforcement,Positive Reinforcement,Psychological Reinforcement,Reinforcement (Psychology),Negative Reinforcements,Positive Reinforcements,Psychological Reinforcements,Psychology Reinforcement,Psychology Reinforcements,Reinforcement, Negative,Reinforcement, Positive,Reinforcement, Psychological,Reinforcements (Psychology),Reinforcements, Negative,Reinforcements, Positive,Reinforcements, Psychological,Reinforcements, Psychology
D003216 Conditioning, Operant Learning situations in which the sequence responses of the subject are instrumental in producing reinforcement. When the correct response occurs, which involves the selection from among a repertoire of responses, the subject is immediately reinforced. Instrumental Learning,Learning, Instrumental,Operant Conditioning,Conditionings, Operant,Instrumental Learnings,Learnings, Instrumental,Operant Conditionings
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005108 Extinction, Psychological The procedure of presenting the conditioned stimulus without REINFORCEMENT to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure. Psychological Extinction,Extinction (Psychology),Extinctions (Psychology),Extinctions, Psychological,Psychological Extinctions

Related Publications

Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
August 2003, The Journal of pharmacology and experimental therapeutics,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
February 2011, Psychopharmacology,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
July 2007, Genes, brain, and behavior,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
September 2009, Addiction biology,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
January 2005, Pharmacological reports : PR,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
December 2007, Behavioural pharmacology,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
May 1999, Neuroreport,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
September 1999, Psychopharmacology,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
January 2008, Pharmacological reports : PR,
Nathan S Pentkowski, and Felicia D Duke, and Suzanne M Weber, and Lara A Pockros, and Andrew P Teer, and Elizabeth C Hamilton, and Kenneth J Thiel, and Janet L Neisewander
February 2005, Pharmacology, biochemistry, and behavior,
Copied contents to your clipboard!